Utility of anti-Sm, anti-RNP, anti-Ro/SS-A, and anti-La/SS-B (extractable nuclear antigens) detected by enzyme-linked immunosorbent assay for the diagnosis of systemic lupus erythematosus

Arthritis and Rheumatism

Volumn 39, Issue 6, 1996, Pages 1055-1061

  Sánchez Guerrero, Jorge ^a,b   Lew, Robert A ^b   Fossel, Anne H ^b   Schur, Peter H ^b  

^a INSTITUTO NACIONAL DE CIENCIAS MÉDICAS Y NUTRICIÓN SALVADOR ZUBIRÁN   (Mexico)

^b BRIGHAM AND WOMEN S HOSPITAL   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ANTINUCLEAR ANTIBODY; CYCLOPHOSPHAMIDE; DNA ANTIBODY; DOUBLE STRANDED DNA; HYDROXYCHLOROQUINE; IMMUNOSUPPRESSIVE AGENT; PREDNISONE;

ADULT; ARTICLE; DIAGNOSTIC VALUE; ENZYME LINKED IMMUNOSORBENT ASSAY; FEMALE; HUMAN; IMMUNOFLUORESCENCE; INTRAVENOUS DRUG ADMINISTRATION; MAJOR CLINICAL STUDY; MALE; PLEURISY; PRIORITY JOURNAL; SYSTEMIC LUPUS ERYTHEMATOSUS;

ANTIBODIES, ANTINUCLEAR; AUTOANTIGENS; BIOLOGICAL MARKERS; CROSS-SECTIONAL STUDIES; ENZYME-LINKED IMMUNOSORBENT ASSAY; FEMALE; HUMANS; LUPUS ERYTHEMATOSUS, SYSTEMIC; MALE; RIBONUCLEOPROTEINS; RIBONUCLEOPROTEINS, SMALL NUCLEAR; RNA, SMALL CYTOPLASMIC; SENSITIVITY AND SPECIFICITY;

EID: 0029953732     PISSN: 00043591     EISSN: None     Source Type: Journal    
DOI: 10.1002/art.1780390626     Document Type: Article

References (32)

1. Ben-Chetrit E: The molecular basis of the SSA/Ro antigens and the clinical significance of their autoantibodies. Br J Rheumatol 32:396-402, 1993
2. Gripenberg M, Teppo AM, Friman C: Antibodies to Sm and SSA demonstrated by enzyme immunoassay: correlation to clinical manifestations and disease activity in patients with systemic lupus erythematosus. Rheumatol Int 11:209-213, 1991
3. Maddison PJ, Skinner RP, Vlachoyiannopoulos P, Brennand DM, Hough D: Antibodies to nRNP, Sm, Ro (SSA) and La (SSB) detected by ELISA: their specificity and inter-relations in connective tissue disease sera. Clin Exp Immunol 62:337-345, 1985
4. Manoussakis MN, Kistis KG, Liu X, Aidinis V, Guialis A, Moutssopoulos HM: Detection of anti-Ro (SSA) antibodies in autoimmune diseases: comparison of five methods. Br J Rheumatol 32:449-455, 1993
5. Chretien P, Soulie E, Johanet C, Abuaf N: Comparisons of double immunodiffusion, ELISA, western blot and cape blot for the detection of anti-SSA antibody. Study of anti-SSA prevalence in systemic lupus erythematosus. J Autoimmun 7:379-388, 1994
6. Reeves WH, Fisher DE, Lahita RG, Kunkel HG: Autoimmune sera reactive with Sm antigen contain high levels of RNP-like antibodies. J Clin Invest 75:580-587, 1985
7. Griner PF, Mayewski RJ, Mushlin AI, Greenland P: Selection and interpretation of diagnostic test and procedures. Ann Intern Med 94:557-592, 1981
8. Juby A, Johnston C, Davis P: Specificity, sensitivity and diagnostic predictive value of selected laboratory generated autoantibody profiles in patients with connective tissue diseases. J Rheumatol 18:354-358, 1992
9. Hamburger M, Hodes S, Barland P: The incidence and clinical significance of antibodies to extractable nuclear antigens. Am J Med Sci 273:21-28, 1977
10. Tan EM, Cohen AS, Fries JF, Masi AT, McShane DJ, Rothfield NF, Schaller JG, Talal N, Winchester RJ: The 1982 revised criteria for the classification of systemic lupus erythematosus. Arthritis Rheum 25:1271-1277, 1982
11. Arnett FC, Edworthy SM, Bloch DA, McShane DJ, Fries JF, Cooper NS, Healey LA, Kaplan SR, Liang MH, Luthra HS, Medsger TA Jr, Mitchell DM, Neustadt DH, Pinals RS, Schaller JG, Sharp JT, Wilder RL, Hunder GG: The American Rheumatism Association 1987 revised criteria for the classification of rheumatoid arthritis. Arthritis Rheum 31:315-324, 1988
12. Subcommittee for Scleroderma Criteria of the American Rheumatism Association Diagnostic and Therapeutic Criteria Committee: Preliminary criteria for the classification of systemic sclerosis (scleroderma). Arthritis Rheum 23:581-590, 1980
13. Bohan A, Peter JB: Polymyositis and dermatomyositis. N Engl J Med 292:344-347, 1975
14. Fox RI, Robinson C, Curd J, Kozin F, Howell FV: First international symposium on Sjögren's syndrome: suggested criteria for classification. Scand J Rheumatol Suppl S61:28-30, 1986
15. Gonzalez EN, Rothfield N: Immunoglobulin class and pattern of nuclear fluorescence in SLE. N Engl J Med 274:1333-1338, 1966
16. Schur PH, DeAngelis D, Jackson JM: Immunological detection of nucleic acids and antibodies to nucleic acids and nuclear antigens by counterimmunoelectrophoresis. Clin Exp Immunol 17:209-218, 1974
17. Eaton RB, Schnneider G, Schur PH: Enzyme immunoassay for antibodies to native DNA: specificity and quality of antibodies. Arthritis Rheum 26:52-62, 1983
18. Shiel WC Jr, Jason M: The diagnostic associations of patients with antinuclear antibodies referred to a community rheumatologist. J Rheumatol 16:782-785, 1989
19. Field M, Williams DG, Charles P, Maini RN: Specificity of anti-Sm antibodies by ELISA for systemic lupus erythematosus: increased sensitivity of detection using purified peptide antigens. Ann Rheum Dis 47:820-825, 1988
20. Delpech A, Gilbert D, Daliphard S, le Loet X, Godin M, Tron F: Antibodies to Sm, RNP and SSB detected by solid-phase ELISAs using recombinant antigens: a comparison study with counter immunoelectrophoresis and immunoblotting. J Clin Lab Anal 7:197-202, 1993
21. Thompson D, Juby A, Davis P: The clinical significance of autoantibody profiles in patients with systemic lupus erythematosus. Lupus 2:15-19, 1993
22. Barada FA Jr, Andrews BS, Davis JS IV, Taylor RP: Antibodies to Sm in patients with systemic lupus erythematosus: correlation of Sm antibody titers with disease activity and other laboratory parameters. Arthritis Rheum 24:1236-1244, 1981
23. Bell DA, Komar R, Chodirker WB, Block J, Cairns E: A comparison of serologic reactivity among SLE patients with or without anti-Ro (SS-A) antibodies. J Rheumatol 11:315-317, 1984
24. Wasicek CA, Reichlin M: Clinical and serological differences between systemic lupus erythematosus patients with antibodies to Ro versus patients with antibodies to Ro and La. J Clin Invest 69:835-843, 1982
25. Munves EF, Schur PH: Antibodies to Sm and RNP. Arthritis Rheum 26:848-853, 1983
26. Maddison P, Mogavero H, Provost TT, Reichlin M: The clinical significance of autoantibodies to a soluble cytoplasmic antigen in systemic lupus erythematosus and other connective tissue diseases. J Rheumatol 6:189-195, 1979
27. Mond CB, Peterson MGE, Rothfield NF: Correlation of anti-Ro antibody with photosensitivity rash in systemic lupus erythematosus patients. Arthritis Rheum 32:202-204, 1989
28. Winn DM, Wolfe JF, Lindberg DA, Fristoe FH, Kingsland L, Sharp GC: Identification of a clinical subset of systemic lupus erythematosus by antibodies to the Sm antigen. Arthritis Rheum 22:1334-1337, 1979
29. Yasuma M, Takasaki Y, Matsumoto K, Kodama A, Hashimoto H, Hirose SI: Clinical significance of IgG anti-Sm antibodies in patients with systemic lupus erythematosus. J Rheumatol 17:469-475, 1990
30. Gulko PS, Reveille JD, Koopman WJ, Burgard SL, Bartolucci AA, Alarcon GS: Survival impact of autoantibodies in systemic lupus erythematosus. J Rheumatol 21:224-228, 1994
31. Hennekens CH, Buring JE: Screening: Epidemiology in Medicine. Edited by SL Mayrent, Boston, Little, Brown and Company, 1987
32. Arnett FC, Hamilton RG, Roebber MG, Harley JB, Reichlin M: Increased frequencies of Sm and nRNP autoantibodies in American blacks compared to whites with systemic lupus erythematosus. J Rheumatol 15:1773-1776, 1988